HIV Infections: all 4,342 studies
Page 24 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT01438606Phase 1
- Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144Status unknownNCT01435135Phase 2
- Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV InfectionCompletedNCT01434706Not applicable
- Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment FailureStatus unknownNCT01433601Not applicable
- Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIVCompletedNCT01433185Not applicable
- Safety Study of Maraviroc's Effect on Human OsteoclastsCompletedNCT01428986
- Safety and Immunogenicity of HIVAX in HIV-1 Infected SubjectsStatus unknownNCT01428596Phase 1
- Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable
- Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)CompletedNCT01423825Phase 1
- HCV/HIV Coinfection: Antiviral Therapy and FibrosisCompletedNCT01423643
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected PatientsCompletedNCT01422330Phase 4
- Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining EventsCompletedNCT01417949Phase 4
- Residual Risk Assessment Of HIV TransmissionCompletedNCT01413152Not applicable
- Centralized Off-Site Adherence Enhancement ProgramCompletedNCT01409655Not applicable
- Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV VaccineCompletedNCT01407497Phase 1
- Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIVCompletedNCT01407237
- Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV CareCompletedNCT01406626Not applicable
- A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female SubjectsCompletedNCT01403792Phase 1
- Project RAP: Family-based HIV Prevention in the Juvenile Drug CourtCompletedNCT01403298Not applicable
- Stanford Universities: The Stanford HIV Aging CohortCompletedNCT01401348
- HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan YouthCompletedNCT01401335Not applicable
- Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in EuropeCompletedNCT01389310
- HIV Diagnosis in Hospitalized Malawian InfantsCompletedNCT01388452Not applicable
- Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionCompletedNCT01386294Phase 3
- Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected WomenCompletedNCT01385241Not applicable
- Relative Bioavailability Study of a Pediatric Granule Formulation of DolutegravirCompletedNCT01382238Phase 1
- Immune Response to Seasonal Influenza Vaccine in HIV Infected IndividualsCompletedNCT01381029
- Spatial Epidemiology of HIV InfectionCompletedNCT01377272
- Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical TrialsCompletedNCT01376726Phase 1
- Non-interventional Study on Use of Darunavir With Ritonavir in Clinical PracticeCompletedNCT01375881
- A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected VolunteersCompletedNCT01371175Phase 2
- Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)TerminatedNCT01367210Phase 4
- Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination TabletsCompletedNCT01366547Phase 1
- Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal RingCompletedNCT01363037Phase 1
- Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected PatientsCompletedNCT01359800
- Role of HIV on Glutathione Synthesis and Oxidative StressCompletedNCT01355198Phase 1
- Dolutegravir Renal Impairment StudyCompletedNCT01353716Phase 1
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV InfectionCompletedNCT01350648
- Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDSCompletedNCT01349062Phase 3
- Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023CompletedNCT01348516Phase 1
- Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE StudyCompletedNCT01348282Phase 4
- Improving Antiretroviral Medication Adherence Among HIV-infected YouthCompletedNCT01347437Not applicable
- Human Immune Responses Toward HIV-1 Envelope AntigensCompletedNCT01344941
- Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA KitCompletedNCT01344642
- Text Messaging Intervention to Improve HIV Adherence in Rural Drug UsersCompletedNCT01343654Not applicable
- Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV InfectionStatus unknownNCT01343225Phase 4
- A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWithdrawnNCT01337583Phase 3
- A Safety and Efficacy Trial of Dapivirine Vaginal Ring in AfricaWithdrawnNCT01337570Phase 3
- Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in WeightCompletedNCT01335360
- The Role of Inflammation and Aging in HIV-Associated Cardiovascular RiskCompletedNCT01333644
- Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin RegimenCompletedNCT01332955Phase 2
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese SubjectsCompletedNCT01332565Phase 1
- HIV and Drug Use in Georgian WomenCompletedNCT01331460Not applicable
- Dating Violence and HIV Prevention in Girls: Adapting Mental Health InterventionsStatus unknownNCT01326195Phase 1
- Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion SurveyCompletedNCT01322932
- Managerial Database IICompletedNCT01322217
- The VMVN Study: Virological Monitoring in Viet NamCompletedNCT01317498Not applicable
- Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for TuberculosisStatus unknownNCT01315301Not applicable
- Study of Human Papillomavirus Related Genital Pathology Among HIV Positive WomenCompletedNCT01311752
- Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance TherapyCompletedNCT01307488Phase 4
- An Automated, Tailored Information Application for Medication Health LiteracyCompletedNCT01304186Not applicable
- Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg DoseCompletedNCT01300988Phase 1
- Progression of HIV-Disease Under Low Dose CorticosteroidsCompletedNCT01299948Phase 2
- Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV InfectionCompletedNCT01297127
- Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus DarunavirCompletedNCT01294761Not applicable
- Structured Treatment Interruption (STI) in Acute/Primary HIVStatus unknownNCT01293513Not applicable
- Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic CirrhosisCompletedNCT01289951Phase 1
- Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult SubjectsStatus unknownNCT01289106Phase 3
- TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and RaltegravirCompletedNCT01288755Phase 1
- Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor RaltegravirCompletedNCT01288417Phase 1
- The Pharmacology/Aging ClinicCompletedNCT01286623
- Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate VaccineCompletedNCT01285141Phase 1
- Assessment of Normal Value of Acoustic Radiation Force Impulse (ARFI) Elastography in HIV PatientsStatus unknownNCT01283243
- A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.WithdrawnNCT01283100Phase 1
- Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.WithdrawnNCT01276990Phase 1
- Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.CompletedNCT01275443Phase 1
- A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult SubjectsWithdrawnNCT01273103Phase 1
- The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK)CompletedNCT01271894Phase 3
- A Randomized Controlled Trial of the Bruthas ProjectCompletedNCT01270230Phase 2
- Recovery Management Intervention in ChinaCompletedNCT01270100Not applicable
- Cohort of Young Adults Infected With HIV Since Birth or During ChildhoodCompletedNCT01269632Not applicable
- Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected AdultsCompletedNCT01266616Phase 1
- Safety and Immunogenicity Study of 2 Investigational Preventive HIV VaccinesCompletedNCT01264445Phase 1
- Pilot Study of Metabolic Syndromes and HIV Infections in Indian TibetansCompletedNCT01261221
- The Study of the Prevalence of Helicobacter Pylori Infection Among HIV/AIDS CohortCompletedNCT01261208
- Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected AdultsCompletedNCT01260727Phase 1
- Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With KaletraStatus unknownNCT01259219Phase 1
- Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase ICompletedNCT01253850
- Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected SubjectsCompletedNCT01252641Phase 1/2
- Impact of Raltegravir on the Viral ReservoirsWithdrawnNCT01249560
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)CompletedNCT01246804Phase 1
- A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in BelgiumWithdrawnNCT01242579Phase 1
- Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.CompletedNCT01237444Phase 3
- Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)Status unknownNCT01232660Phase 1
- Acceptability Study of Vaginal Films for HIV PreventionCompletedNCT01231763
- Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female VolunteersCompletedNCT01231542Phase 1
- GSK1349572 Hepatic Impairment StudyCompletedNCT01231529Phase 1
- Depot Contraception With and Without Lopinavir/RitonavirWithdrawnNCT01231451Phase 1
- Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)Status unknownNCT01230580Phase 4